Lag between COVID-19 vaccine boosters, new variants highlight need for therapeutics, expert says

105920

Sumary of Lag between COVID-19 vaccine boosters, new variants highlight need for therapeutics, expert says:

  • It takes six months, at best, to tweak previously authorized vaccines to target specific variants, he said, with the time frame of 12 months looking more likely..
  • NRx is also seeking emergency use authorization for aviptadil-acetate, Zyesami, a vasoactive intestinal polypeptide to treat severely ill coronavirus patients..
  • Late-stage trial results among 196 critically ill coronavirus patients included an over four-fold improvement in odds of survival over 60 days among those given the intravenous drug, he said..
  • The National Institutes of Health is also running a late-stage trial testing the drug up against the previously-approved antiviral remdesivir..
  • The protein works by protecting a major target for the virus in the lungs, called alveolar type II cells, Javitt explains….

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close